Dysregulation of the vascular endothelial growth factor and semaphorin ligand-receptor families in prostate cancer metastasis

BACKGROUND: The vascular endothelial growth factor (VEGF) family is central to cancer angiogenesis. However, targeting VEGF as an anti-cancer therapeutic approach has shown success for some tumor types but not others. Here we examine the expression of the expanded VEGF family in prostate cancer, inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Bender, R. Joseph, Mac Gabhann, Feilim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559909/
https://www.ncbi.nlm.nih.gov/pubmed/26341082
http://dx.doi.org/10.1186/s12918-015-0201-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559909/
https://www.ncbi.nlm.nih.gov/pubmed/26341082
http://dx.doi.org/10.1186/s12918-015-0201-z

Ejemplares similares